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Summary In the neurology literature it is well established that anti-epileptic drugs
(AEDs) lead to bone loss (osteopenia and osteoporosis). Several large epidemiologic
studieshave foundtwice the fracture rate inpersonswithepilepsycompared to thenon-
epilepsy population. While an increasing level of awareness for preventative measures
and screening by neurologists and primary care physicians are recommended, so far no
one has attempted to address how knowledge related to calcium and exercise, health
beliefs (based on the Health Belief Model) and self-efficacy (confidence in abilities)
impact osteoprotective behaviors in epilepsy, based on thePrecautionAdoption Process
Model (PAPM). The seven-stage PAPM, unlike other health behavior theories where a
person is either practicing or not practicing the behavior, conceptualizes behavior
change as dynamic and occurring over time. Validated instruments were used to assess
knowledge, health beliefs, self-efficacy and stages of the precaution adoption process
for four osteoprotective behaviors. For dietary calcium; exercise knowledge and
calcium self-efficacy predicted higher stages of precaution adoption. For calcium
supplements; age perceived susceptibility for osteoporosis and perceived benefits of
calcium predicted higher stages. Exercise adoption stage was most predicted by
exercise knowledge and health motivation. For DEXA screening adoption; age and
perceived susceptibility predicted higher stages. This study provides hints how persons
with epilepsy could be influenced to move from the unaware/unengaged positions into
to the stages of adoption and maintenance for osteoprotective behaviors.
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An estimated 1.5 million people suffer a bone-dis-
ease related fracture annually in the U.S.1 Two
recent large cohort studies found double the frac-
ture incidence in persons with epilepsy when com-
pared to a non-epilepsy population.2,3 It has been
demonstrated that bone loss can occur after as little
as 2 years of antiepileptic drug (AED) exposure.4 A
survey by Epilepsy Action found 75% of members
reported never being told about osteoporosis/
osteomalacia as a possible side effect of long-term
(>5 years) use of AEDs. Of those who were informed
of bone health issues, their epilepsy specialist was
reported as the primary source of this information.5
Ninety percent of patients reported wanting more
information about epilepsy and 75% reported they
were not given enough information about the side
effects of antiepileptic drugs.6
Adequate calcium intake in adolescence can
result in a 5—10% difference in peak bone mass
and may be able to reduce the risk of hip fracture
by 50%.7 Regular physical activity increases muscle
and bone strength, increases lean muscle and
decreases body fat.8 Based on results of the Centers
for Disease Control’s Behavioral Risk Surveillance
System in 2001, only 45% of US adults surveyed
engaged in physical activity at recommended levels
(i.e. 20 min per day, 3 days per week).9
Persons with epilepsy report significantly less
physical activity and higher rates of obesity,10 how-
ever they do believe exercise may improve their
medical treatment.11 A majority of persons with
epilepsy have no adverse effects from exercise
and up to 36% have reported that regular exercise
contributed to better seizure control.12 Since the
benefits of exercise for osteoporosis do not persist
without regular participation, the challenge is to
not only increase adoption in those who are seden-
tary but also to develop education and programs
that promote the maintenance of exercise once it
has been established.13Osteoporosis knowledge
Educational interventions focused on osteoporosis
have been able to increase knowledge but have not
resulted behavior change.14 Women diagnosed with
osteoporosis score higher than a general sample on
osteoporosis knowledge tests,15 however scores
were not associated with calcium intake or weight
bearing exercise. Studies of men have also found
poor knowledge.16 Overall, level of education
seems to be the best predictor of knowledge
scores.17Perceived susceptibility for
osteoporosis
The study of behavioral aspects related to osteo-
porosis prevention, diagnosis and treatment in the
general population have revealed that most people
at risk do not view osteoporosis with concern.18 This
is disconcerting since one out of every two Cauca-
sian women may experience an osteoporotic frac-
ture in their lifetime.19 Studies of non-Caucasian
populations have found similar concerns relating to
osteoporosis knowledge and health behavior.20,21
Studies of men have also found a lack of perceived
susceptibility with few engaging in preventative
behaviors such as weight-bearing exercise, increas-
ing dietary calciumor supplementation.16 The rate of
fracture related mortality, 1-year post-hip fracture,
is double in men compared to women.16,22 Males on
AEDs have been found to have a 1.8% annual loss of
bone mineral density, yielding a 2.5-fold increased
prevalence of bone loss at the hip when compared to
the healthy U.S. male population.23Health behavior models/theories
Stages of change models
A ‘‘stages of change’’ model posits that preventative
behaviors are adopted through a series of decisional
changes. Stages of change models work in a variety
of populations,24 age groups25 as well as for specific
health concerns such as osteoporosis,26 calcium
intake27 and exercise.28,29 Stage matched interven-
tions have improved progress towards higher stages
of adoption in employee exercise programs.30 Clas-
sifying people by stage of adoption has been useful
in that subjects grouped by stage tend to share
similar knowledge, beliefs, attitudes and perceived
barriers for the specific behavior and they often
have a different pattern of these attributes than
people in other stages.31
The Precaution Adoption Process Model
The Precaution Adoption Process Model (PAPM),
described in Fig. 1,32 is based on the stages of change
concept. The seven-stage PAPM, unlike other health
behavior theories where a person is either practicing
or not practicing the behavior, conceptualizes beha-
vior change as dynamic and occurring over time.33
The PAPM (and other stage models) suggest that
people at different points in the precaution adoption
process behave in qualitatively different ways and
that the types of interventions and information
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Figure 1 Stages of the Precaution Adoption Process Model (source: Ref. [32]).needed to move people closer to action varies from
stage to stage.34 Although the PAPM does not provide
a fixed set of variables that differentiate between
stage or foster progression from stage to stage,35 it is
thought that between stages an individual’s health
beliefs and perceptions (perceived susceptibility,
perceived severity, barriers, benefits and self-effi-
cacy) are critical for action. People in action and
maintenance have often changed their behavior and
in these stages self-efficacy (confidence inabilities) is
likely based on experience rather than perception.36
The model assumes people move through the
sequence in order, without skipping stages. How-
ever, there is no minimum amount of time one will
spend in each stage and people can regress in their
stage.37 The PAPM has been used to study adoption
of behaviors related to osteoporosis,33,38,39 mam-
mography screening40 and home radon testing.37 In a
study of postmenopausal women recently admitted
for a low-impact fracture, 62% were in Stage 1 or 2 of
the PAPM and only a previous diagnosis of osteo-
porosis was associated with a more advanced stage
of patient readiness to accept treatment after a
fracture.39 Another reason for determining where
people are in the stage of a behavior has been in the
benefits of utilizing education programs and mate-
rials designed to move people along in the stage
process.41 Traditionally, many programs (i.e. smok-
ing cessation) are designed for the small number ofFigure 2 The Health Belief Modepeople who are already prepared to change their
behavior or adopt a new behavior.
Health Belief Model
The Health Belief Model (HBM), seen in Fig. 2,42 has
been used to explain health behavior in osteoporosis
research.39,43 The HBM states that perception of a
health behavior threat is influenced by general
health values (interest and concern about health),
beliefs about vulnerability to a health threat and
beliefs about the consequences of a health problem.
Once an individual perceives a threat to their
health, has been cued (internally or externally) to
action, and their perceived benefits outweighs the
perceived barriers, then the individual is most likely
to undertake a recommended preventive health
action. Demographic variables, perceived threat,
and cues to action (family history, screening test
results or discussions with a health professional) act
as modifying factors.
Self-efficacy
Self-efficacy beliefs (confidence in abilities) deter-
mine how people feel, think, motivate themselves
and behave.44 Individuals with greater self-efficacy
beliefs are more likely to engage in healthy beha-
viors, maintain these behaviors and to recover froml (diagram source: Ref. [42]).
Precaution adoption process model in epilepsy 427setbacks.45 Baseline self-efficacy and changes in
self-efficacy are associated with future health sta-
tus.46 The literature supports the importance of
self-efficacy in influencing and predicting health
behavior in the areas of smoking cessation, coronary
artery disease, weight loss, pulmonary disease,
arthritis and diabetes.47 It follows that a similar
pattern may exist in persons with epilepsy since it
is often a chronic condition.
Self-efficacy has been incorporated into a stage
model for calcium intake27 and exercise28 showing it
predicts strongly stage membership with those in
the lower stages having the lowest self-efficacy
scores and those in maintenance having the highest.
Self-efficacy is considered one of the most consis-
tent predictors of adherence to exercise.48
Epilepsy self-efficacy
Chronic disease is a major cause of disability and has
been estimated to account for 70% of all health care
expenditures. It is also one of the main reasons
people seek health care.49 Only one-third of
patients are believed to adhere to their prescribed
medical regimens.47 Self-management tasks are
extensive–—they involve medical management (tak-
ing medication or following a specific diet), main-
taining, changing and creating new behaviors as well
as the emotional effects of a chronic condition
which changes one’s view of the future.46 Self-
management of epilepsy, like other chronic health
conditions, requires a high level of self-efficacy.50
To date, in the study of bone loss in epilepsy,
there has been little emphasis on the psychosocial
aspects related to the adoption of osteoprotective
behavior. Our plan was to strategically take vali-
dated health behavior concepts (the Health Belief
Model and self-efficacy) along with domain specific
knowledge scales (calcium and exercise) in order to
determine their ability to discriminate people
among the stages of change based on the Precaution
Adoption Process Model. In the clinical setting,
patient education based upon principles of health
behavior, may improve opportunities for prevention
related to dietary calcium, calcium supplements,
physical exercise and dual emitting X-ray absorptio-
metry (DEXA) screening. Previous research has
found that few people are in the same stage when
looking at multiple health behaviors.51
On the basis of established health behavior the-
ories (the Health Belief Model and self-efficacy) we
believed persons in the higher stages of the PAPM
would perceive more benefits and less barriers for
osteoprotective behaviors, as well as a greater level
of perceived susceptibility for osteoporosis. We also
theorized that persons in the higher stages of thePAPM would have higher levels of perceived self-
efficacy related to osteoprotective behaviors. On
the basis of previous studies we also expected to see
persons in the more advanced stages (those who
have adopted the behavior) to possess greater
knowledge of calcium and exercise than those in
lower stages (those who have not thought about
adopting a specific behavior).Methods
Ninety-four epilepsy clinic subjects, age 18 years or
older (range 19—78), participated in the study.
Subjects were recruited from the Temple University
School of Medicine Department of Neurology out-
patient clinic. Data collection took place over a 6-
month period. Inclusion criteria included patients
age 18 or older with a diagnosis of epilepsy. Exclu-
sion criteria included patients with mental retarda-
tion, learning disability, Alzheimer’s, dementia or
schizophrenia. Five hundred patients (seen in the
past 4 years) were deemed eligible to complete the
survey based on chart review. Eighty-three patients
were approached to participate at clinic visits and
142 surveys were mailed to eligible patients who
were not coming in for an office visit in the upcoming
months. The response rate to our questionnaire was
42%. Of those approached at clinic 27 (33%) com-
pleted surveys and of those who were mailed sur-
veys 67 (47%) completed and mailed them back. The
Temple University Institutional Review Board
approved this study and written informed consent
was obtained from each participant.
Instruments
Subjects completed seven sections in the question-
naire. A questionnaire based on the Precaution
Adoption Process Model (PAPM) was adapted from
previous studies33,38 and used to assess the PAPM
stage for four preventative behaviors: dietary cal-
cium, calcium supplements, exercise and bone den-
sity screening by dual energy X-ray absorptiometry
(DEXA).
The osteoporosis knowledge test (OKT) is a 24-
itemmultiple-choice test designed by Kim et al.52 to
measure knowledge of risk factors for osteoporosis
and strategies for prevention related to exercise
and calcium. There are two sub-scales for the OKT:
calcium and exercise. OKTexercise subscale internal
consistency coefficient (a measure of reliability)
called Cronbach’s alpha was .69. The OKT calcium
subscale Cronbach’s alpha was .72. Validity of the
OKT was evaluated by factor analysis and discrimi-
nant function analysis.52
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was designed by Kim et al.53 to assess the perception
of risk related to osteoporosis and health beliefs
related into prevention based on the Health Belief
Model, seen in Fig. 2.53 The OHBS has 42 items
grouped in seven subscales: perceived susceptibility
of osteoporosis, perceived seriousness of osteoporo-
sis, barriers to calcium intake, barriers to exercise,
benefits of calcium intake, benefits of exercise and
health motivation. Each item is scored using a Likert
scale with one as ‘‘strongly disagree’’ to five for
‘‘strongly agree’’. Cronbach’s alpha reliability coef-
ficients ranged from .61 (health motivation) to .80
(susceptibility) in an early development and evalua-
tion study.52 Updated reliability coefficients were
found to be .76 for the OHBS Calcium subscale and
.77 for the OHBS exercise subscale.
The Osteoporosis Self-Efficacy Scale (OSES) was
designed by Horan et al.54 to measure the level of
confidence for an individual in undertaking osteo-
porosis preventive measures. The questionnaire has
twelve items separated in two sub-scales: OSES cal-
cium andOSES exercise. The confidence on each item
is rated by placing an ‘‘X’’ on a 100 mm line that has a
range from 0 as ‘‘not at all confident’’ up to 100 as
‘‘very confident’’. Cronbach’s alpha for the calcium
andexercise sub-scaleswas .93 and .94, respectively.
Validity of the 12 item OSES was evaluated by factor
analysis and discriminate function analysis.
The Epilepsy Self-Efficacy Scale (ESES) is a 33
question, Likert scale survey. Each item is rated on
an 11-point scale of 0—10, with 0 being ‘‘I cannot do
at all’’ and 10 being ‘‘Sure I can do’’. The ESES
measures the degree of confidence that individuals
have in their ability to successfully perform tasks in
the areas of medication management, seizure con-
trol and general epilepsy management.50,55—57 Total
score ranges from 0 to 330, with higher scores indi-
cating higher levels of self-efficacy. Content and
construct validity have been assessed and ratings
of individual items demonstrated 94% agreementTable 1 Distribution among stages of the Precautionary Ad
Stage n (%)
Ca diet Ca su
1. Unaware 8 (8.5) 9 (9
2. Unengaged 22 (23.4) 21 (2
3. Deciding 1 (1.1) 2 (2
4. Decided against 9 (9.6) 6 (6
5. Decided to act 5 (5.3) 2 (2
6. Acting 11 (11.7) 13 (1
7. Maintenance 35 (37.2) 40 (4
Missing 3 (3.2) 1 (1
Ca: calcium, DEXA: dual energy X-ray absorptiometry.among an expert panel, which included Bandura,
the originator of self-efficacy theory. Cronbach’s
alpha for several studies ranged from .93 to .94.55
Each subject also completed a demographic ques-
tionnaire. Information requested included age, gen-
der, ethnicity, marital status, education, yearly
income, working status, height, weight, smoking/
alcohol use, bone fracture history, family history of
osteoporosis, calcium/multivitamin use, age of epi-
lepsy diagnosis, number of AEDs presently taken,
seizure frequency, insurance status, prescription
coverage and driving status. Missing demographics
items were gathered from the clinic chart when
necessary.
Data analysis plan
The analytic plan of this study followed a specific
progression. To simplify analyses stages were com-
bined; stages 1 and 2 were defined as unaware/
unengaged, stages 3—6 defined as deciding/acting
and stage 7 defined as maintenance. This decision
was made due to the distribution of persons (some
stages had very few people) and for the purposes of
more meaningful statistical analysis (see Table 1).
While not consistent with the model this strategy
has been utilized by other researchers.31,38,39,58
Descriptive statistics were determined first. Ana-
lysis of variance was used to examine the relation-
ship between stage and the predictor variables
(health belief scales, knowledge and self-efficacy).
Then, we performed a bivariate (Pearson correla-
tions) analysis to examine relationships between the
dependent and independent variables as well as to
identify redundancy among independent variables.
Correlations provided insight into the variables that
would likely hold up in the multivariate discriminant
analysis.
Stepwise discriminant analysis was used to deter-
mine which predictors had independent effects on
the stage classification. This helps in identifyingoption Process Model by 4 osteoprotective behaviors
pplements Exercise DEXA
.6) 12 (12.8) 20 (21.3)
2.3) 9 (9.6) 8 (8.5)
.1) 1 (1.1) 2 (2.1)
.4) 7 (7.4) 4 (4.3)
.1) 15 (16.0) 6 (6.4)
3.8) 15 (16.0) 14 (14.9)
2.6) 33 (35.1) 37 (39.4)
.1) 2 (2.1) 3 (3.2)
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Table 2 Demographics of participants
Variables n (%)
Female 66 (70)
Ethnicity
Caucasian 50 (53)
African American 32 (34)
Latino 12 (13)
Marital status
Single 48 (51)
Married 33 (35)
Separated/divorced/widowed 13 (14)
Employment status
Full time 26 (28)
Part time 11 (12)
Not working 57 (61)
Yearly income
Under $ 10,000 29 (31)
$ 10,000—30,000 24 (26)
Greater than $ 30,001 22 (23)
Missing 19 (20)
Has prescription coverage 72 (77)
On medical assistance 36 (38)
Presently has a driver’s license 38 (40)
Body mass index
Underweight 3 (3)
Normal 32 (34)
Overweight 18 (19)
Obesity 40 (43)
Reports cigarette use 13 (14)
Reports alcohol use 14 (15)
History of fracture 37 (40)
Diagnosed with bone loss 24 (26)
Taking an osteoporosis Medication 13 (14)
family history of osteoporosis 17 (18)
Presently taking calcium 41 (44)
Presently taking a multivitamin 60 (64)
Last reported seizure
Within last 1 month 42 (45)
Between 2 and 12 months 27 (29)
Greater than 12 months 25 (26)
Present number of AEDs
One 46 (49)
Two 33 (35)
Three 13 (13)
Four 1 (2)which health behaviors variables are most likely to
predict stage of behavior change. Potential con-
founders such as age, gender, ethnicity, income,
medical assistance status, family history and frac-
ture history were also evaluated. Discriminant func-
tions are uncorrelated dimensions along which
groups differ reliably. The functions indicate which
specific variables predict differences between indi-vidual groups, the first function provides the best
separation among groups.43 Canonical discriminant
analysis was used to derive the linear combinations
of the variables that best explained the between
stage variation.Results
Demographics
This was an adult epilepsy population with a mean
age of 45 years (S.D. = 12.9, range 19—78), there
were 28 males and 66 females. These individuals
included both young and old individuals and those
newly diagnosed with epilepsy. Surveys were given
to 98 Caucasians (44%), 85 African Americans (38%),
34 Latinos (15%) and 6 Asian/other (<1%). More
women66 completed surveys than men28 which
was not unexpected since women represented
61% of the outpatient database. Fifty subjects were
Caucasian, 32 were African American, and 12 were
Latino. The average length of antiepileptic drug
(AED) exposure was 20 years (S.D. = 13.9, range
1—50). All demographic variables are displayed in
Table 2.
Health beliefs
Based on one-way ANOVA for adoption of dietary
calcium, persons in the maintenance stage had
greater knowledge for exercise (F = 7.41,
p = .001) and calcium (F = 4.06, p = .021) as well
as greater perceived susceptibility (F = 3.72,
p = .028), see Table 3. For the adoption of calcium
supplements, those in maintenance had higher cal-
cium knowledge scores (F = 4.47, p = .014) as well as
greater perceived susceptibility (F = 8.55,
p = .000). For the adoption of exercise, persons in
maintenance had higher scores for knowledge
related to exercise (F = 7.30, p = .001) and calcium
(F = 5.05, p = .001), perceived benefits of exercise
(F = 7.30, p = .001) and health motivation (F = 4.35,
p = .016), as well as lower levels of perceived bar-
riers for exercise (F = 4.71, p = .011) and calcium
(F = 5.05, p = .008). Individuals in the maintenance
stage for the adoption of DEXA screening had higher
knowledge scores for exercise (F = 3.40, p = .038)
and calcium (F = 3.96, p = .023) as well as greater
perceived susceptibility (F = 3.85, p = .025).
Self-efficacy
Higher levels of self-efficacy for exercise (F = 3.43,
p = .037) and calcium (F = 5.71, p = .008) were
found for those in the maintenance stage for dietary
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Table 3 Osteoporosis Health Belief Scales by recoded precaution adoption process stage (mean scores (S.D.))
Frequency OKT
exercise
OKT
calcium
Susceptibility Seriousness Benefits
exercise
Benefits
calcium
Barriers
exercise
Barriers
calcium
Health
motivation
Calcium diet
Unaware/unengaged 30 6.0 (3.1) *** 6.8 (3.4) * 16.7 (4.5) * 19.5 (5.0) 22.3 (3.3) 22.6 (3.6) 14.5 (5.1) 15.1 (4.0) 22.3 (4.2)
Deciding/acting 26 6.7 (3.4) *** 8.2 (3.9) * 19.2 (4.7) * 19.5 (4.2) 21.6 (4.9) 23.1 (4.2) 15.8 (9.7) 14.1 (4.8) 22.6 (4.5)
Maintenance 35 8.9 (2.9) *** 9.3 (3.2) * 20.1 (6.0) * 18.7 (4.6) 23.3 (3.7) 23.4 (3.4) 12.6 (5.1) 12.7 (4.7) 24.5 (3.1)
Calcium supplements
Unaware/unengaged 30 6.2 (3.1) 6.5 (3.6) * 15.7 (4.5) *** 19.4 (4.6) 21.8 (4.0) 22.3 (3.5) 15.0 (4.6) 15.4 (4.2) 22.8 (4.3)
Deciding/acting 23 7.8 (3.2) 8.6 (3.3) * 18.8 (5.2) *** 19.5 (4.6) 23.0 (4.7) 23.7 (4.0) 15.9 (10.6) 14.3 (4.6) 23.2 (5.0)
Maintenance 40 7.7 (3.5) 9.0 (3.6) * 20.7 (5.3) *** 19.0 (4.7) 22.9 (3.5) 23.5 (3.6) 12.6 (4.8) 12.8 (4.5) 23.5 (3.0)
Exercise
Unaware/unengaged 21 5.1 (3.2) ** 5.8 (3.0) *** 18.6 (4.4) 20.2 (4.9) 19.9 (3.5) *** 23.5 (3.9) 16.4 (5.6) * 16.5 (4.0) ** 21.5 (3.7) *
Deciding/acting 38 7.6 (3.2) ** 8.3 (3.5) *** 19.3 (5.2) 19.6 (5.1) 22.6 (4.0) *** 22.3 (4.1) 15.3 (8.6) * 13.3 (4.6) ** 22.9 (4.1) *
Maintenance 33 8.2 (3.2) ** 9.4 (3.6) *** 18.2 (6.0) 18.3 (3.8) 23.9 (3.6) *** 23.3 (3.6) 11.4 (3.7) * 12.9 (4.3) ** 24.6 (3.5) *
DEXA
Unaware/unengaged 28 6.1 (3.3) * 6.9 (3.2) * 16.5 (4.0) * 19.5 (5.1) 21.6 (3.7) 23.2 (3.5) 13.8 (4.9) 14.4 (4.3) 22.8 (4.7)
Deciding/acting 26 7.3 (2.8) * 7.9 (3.2) * 19.4 (4.5) * 20.0 (4.8) 22.3 (4.5) 22.8 (3.6) 16.8 (9.9) 14.6 (4.7) 23.9 (3.4)
Maintenance 37 8.2 (3.5) * 9.3 (3.9) * 19.9 (6.3) * 18.4 (4.1) 23.3 (3.7) 23.2 (3.9) 12.6 (4.8) 13.1 (4.7) 23.0 (3.7)
Note: Precaution adoption stages were recoded as: Stages 1 and 2 = 1 (unaware/unengaged), Stages 3—6 = 2 (deciding/acting) and Stage 7 = 3 (maintenance).
* p  .05.
** p  .01.
*** p  .001.
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Table 4 Self-efficacy scales by recoded Precaution Adoption Process Stagesa (means (S.D.))
Frequency OSES calciumb OSES exercisec ESESd
Calcium diet
Unaware/unengaged 30 60.4 (27.2) ** 59.4 (26.4) * 248.6 (50.0)
Deciding/acting 26 67.4 (30.8) ** 63.5 (30.2) * 244.7 (54.1)
Maintenance 35 80.7 (20.0) ** 74.9 (18.2) * 261.8 (41.1)
Calcium supplements
Unaware/unengaged 30 63.0 (25.4) * 62.6 (24.9) 257.6 (38.3)
Deciding/acting 23 66.2 (31.0) * 61.6 (30.4) 246.9 (60.9)
Maintenance 40 78.7 (23.6) * 72.0 (21.6) 252.1 (46.4)
Exercise
Unaware/unengaged 21 58.7 (24.9) * 55.8 (28.7) 230.0 (36.6)
Deciding/acting 38 68.8 (29.8) * 69.3 (24.4) 257.5 (49.4)
Maintenance 33 79.1 (22.3) * 70.3 (23.4) 257.4 (54.6)
DEXA
Unaware/unengaged 28 60.1 (28.3) 64.2 (23.1) 236.0 (52.5)
Deciding/acting 26 76.5 (23.8) 66.9 (29.2) 263.2 (41.4)
Maintenance 37 73.4 (26.7) 68.0 (25.1) 257.6 (46.9)
a Precaution Adoption Stages recoded as: Stages 1 and 2 = 1 (unaware/unengaged), Stages 3—6 = 2 (deciding/acting) and Stage 7 = 3
(maintenance).
b Osteoporosis Self-Efficacy Scale calcium: measures level of confidence (0—100) in undertaking osteoporosis prevention measures
related to dietary calcium.
c Osteoporosis Self-Efficacy Scale exercise: measures level of confidence (0—100) in undertaking osteoporosis prevention measures
related to physical exercise.
d Epilepsy self-efficacy scale: measures level of confidence (0—330) for managing epilepsy in the areas of medication management
and seizure control.
* p  .05.
** p  .01.calcium (see Table 4). Self-efficacy related to cal-
cium was significantly higher for those in the main-
tenance stage for calcium supplements (F = 3.50,
p = .034) and exercise (F = 3.98, p = .022). For the
adoption of DEXA screening no significant differ-
ences related to self-efficacy were found. There
were no significant differences in the epilepsy
self-efficacy scale among any of the four osteopro-
tective behaviors.
Bivariate analysis
Chi-square analyses were performed for adoption
stages and age (18—34, 35—49, and >50), gender
andethnicity (Caucasian versus non-Caucasian). Only
age with older respondents being in higher stages for
calcium supplement adoption (x2 = 16.11, p = .003)
and ethnicity with Caucasians in higher stages for
DEXA screening adoption (x2 = 10.47, p = .005) were
significant.
Theosteoporosis knowledge test calciumwasposi-
tively correlated with all four osteoprotective beha-
viors assessed by the PAPM (see Table 5). For the
osteoporosis knowledge test exercise subscale; cal-
cium diet, exercise and DEXA were positively corre-
lated. Susceptibility was positively correlated with
dietary calcium, calcium supplements and DEXAscreening. No correlations were seen with serious-
ness or perceived benefits for calcium. Perceived
benefits of exercise were only correlated with the
adoption of exercise. Barriers for calciumwere nega-
tively correlated with dietary calcium, calcium sup-
plements and exercise, while barriers for exercise
were negatively correlated with exercise adoption.
Health motivation was correlated with dietary cal-
cium and exercise. Self-efficacy for calcium was
correlated with all osteoprotective behaviors except
DEXA screening. Self-efficacy for exercise was corre-
latedwith dietary calcium adoption. Self-efficacy for
epilepsy was not correlated with any of the osteo-
protective behaviors assessed by the PAPM.
Discriminant analysis
Stepwise discriminant analysis revealed two signifi-
cant independent predictors for dietary calcium
stage: the knowledge test for exercise F(2,
70) = .895 and calcium self-efficacy F(2, 70) = .898.
When these variables were entered into the canoni-
cal discriminant analysis, the full model was signifi-
cant (Wilks’ l = .788, exact F(4, 138) = 4.36,
p = .002). The first discriminant function explained
96.8% of the variance among participants in different
stages of the precaution adoption process. Stage
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Table 5 Correlations among study variables
Variable 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
Knowledge
1. OKT calcium —
2. OKT exercise .83 *** —
Health beliefs
3. Susceptibility .23 * .12 —
4. Seriousness .28 ** .13 .14 —
5. Benefits calcium .08 .10 .01 .27 ** —
6. Benefits exercise .33 *** .43 *** .03 .05 .30** —
7. Barriers calcium .47 *** .42 *** .01 .31 ** .04 .21 * —
8. Barriers exercise .27 ** .21 ** .01 .15 .03 .21 * .46 *** —
9. Health motivation .06 .09 .06 .04 .12 .14 .12 .14 —
Self-efficacy
10. Calcium .06 .04 .13 .03 .24* .15 .19 .22 * .30 ** —
11. Exercise .19 .15 .09 .16 .06 .21 * .20 .36 *** .27 ** .58 *** —
12. Epilepsy .19 .20 .03 .27 ** .01 .17 .17 .01 .18 .32 ** .35 *** —
Precaution Adoption Process
13. Calcium diet .29 ** .37 *** .27 ** .08 .09 .11 .22 * .12 .24 * .32 ** .26 * .12 —
14. Calcium supplements .28 ** .18 .40 *** .04 .13 .11 .25 * .17 .07 .26 * .17 .04 .51 *** —
15. Exercise .36 *** .33 *** .05 .16 .00 .37 *** .28 ** .29 ** .30 ** .29 ** .20 .19 .33 *** .30 ** —
16. DEXA .29 ** .28 * .26 * .11 .01 .19 .13 .09 .01 .20 .06 .18 .46 *** .50 *** .23 * —
* p  .05.
** p  .01.
*** p  .001.
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Table 6 Standardized discriminant function weights for Predictors of Precautionary Adoption Stage
Standardized discriminant function weights
Calcium diet Calcium Supp Exercise DEXA
1a 2a 1a 2a 1a 2a 1a 2a
Age — — .427 .001 — — .767 .642
Gender — — — — — — — —
Ethnicity — — — — — — — —
Education — — — — — — — —
Yearly income — — — — — — — —
Medical assistance — — — — — — — —
Family history — — — — — — — —
Fracture history — — — — — — — —
OKT calcium — — — — — — — —
OKT exercise .661 .751 — — .641 .767 — —
Susceptibility — — .641 .682 — — .594 .804
Seriousness — — — — — — — —
Benefits calcium — — .420 .791 — — — —
Benefits exercise — — — — — — — —
Barriers calcium — — — — — — — —
Barriers exercise — — — — — — — —
Health motivation — — — — .716 .698 — —
Calcium self-efficacy .647 .762 — — — — — —
Exercise self-efficacy — — — — — — — —
Epilepsy self-efficacy — — — — — — — —
Note: Dashes indicate that the variable was not included in the canonical discriminant function analysis. OKT: osteoporosis knowledge
test, Supp: supplements; DEXA: dual-energy X-ray absorptiometry.
a Predictor.means for this discriminant function increased con-
sistently from the earliest stage (unaware/unen-
gaged) to latest stage (maintenance). The
standardized discriminant function weights shown
in Table 6 indicate that OKT Exercise had the most
effect onparticipant’s scores on thefirst discriminant
function. Rating higher on the knowledge of exercise
for osteoporosis prevention was associated with
higher discriminant function scores. The second dis-
criminant function explained an additional 3.2% of
the between stage variance. Subjects in the middle
stage (deciding/acting) scored highest on this discri-
minant function, which reflects higher self-efficacy
for obtaining calcium from diet or supplements.
Three significant independent predictors for cal-
cium supplement stage: OHBS susceptibility F(2,
70) = .822, OHBS benefits calcium F(2, 70) = .906
and age (recoded) F(2, 70) = .917 were found. When
these variables were entered into the canonical
discriminant analysis, the full model was significant
(Wilks’ l = .65, exact F(6, 136) = 5.42, p = .000).
The first discriminant function explained 95% of
the variance among participants in different stages
of the precaution adoption process. The second
discriminant function explained an additional 5%
of the between stage variance.
Two significant independent predictors for exer-
cise stage were found–—health motivation F(2,70) = .853 and OKT exercise F(2, 70) = .878. When
these variables were entered into the canonical
discriminant analysis, the full model was significant
(Wilks’ l = .748, exact F(4, 138) = 5.39, p = .000).
The first discriminant function explained 99.7% of
the variance among participants in different stages
of the precaution adoption process. The second
discriminant function explained only an additional
0.3%.
Two significant independent predictors for DEXA
stage: age recoded in categories F(2, 70) = .835 and
OHBS susceptibility F(2, 70) = .893 were found.
When these variables were entered into the cano-
nical discriminant analysis, the full model was sig-
nificant (Wilks’ l = .748, exact F(4, 138) = 5.39,
p = .000). The first discriminant function explained
99.3% of the variance among participants in differ-
ent stages of the precaution adoption process. The
second discriminant function explained only an
additional 0.7% of the between stage variance.Discussion
This is the first study of persons with epilepsy to
assess the Precaution Adoption Process Model and
health behavior (knowledge, health beliefs and self-
efficacy) in relation to AED induced osteoporosis.
434 J.O. Elliott et al.The medical literature over the past 20 years has
established a strong link between antiepileptic
medications and metabolic bone loss59; however
the emphasis has primarily been on determining
which AEDs are worse for bone density in various
populations. While clinical guidelines for practi-
tioners in the epilepsy medical literature typically
focus on evaluation of other risk factors, DEXA
screening and general recommendations for exer-
cise and supplementation60 no one has attempted to
assess the decision making process for these osteo-
protective behaviors in epilepsy.
The discriminant function analysis found age to be
a significant predictor of higher stages in the decision
making process for calcium supplements and DEXA.
Clinically, this makes sense as advancing age is typi-
cally the reason that calcium supplements and DEXA
screening are recommended by healthcare profes-
sionals. The knowledge test for exercise was a pre-
dictor for higher stages of dietary calcium and
exercise. This also makes sense in that dietary cal-
cium and exercise are behaviors that require signifi-
cant lifestyle changes from patients. Those who are
highly motivated are likely to be able to make
changes in both preventative areas. For these indi-
viduals, promotingexercise knowledge ismore useful
since they have made a commitment to change their
behavior–—those who are unaware or in the earlier
stages of change are less likely to be motivated by
action-based or knowledge-only interventions thus
supporting the stages of change concept.
Based on the discriminant analysis, perceived
susceptibility for osteoporosis and advancing age,
are predictors of higher stages of calcium supple-
ment use and DEXA screening. Therefore, providing
information about risk appears to help the adoption
of calcium supplements and for screening which
holds with other models of health behavior such
as the Health Belief Model. People are unlikely to
take calcium supplements if they think it will not
benefit them–—supporting the fact that perceived
benefits of calcium predict higher stages of adoption
for calcium supplements.
Health motivation predicts higher stages of adop-
tion for exercise, while not an unexpected finding
also provides support for components of the Health
Belief Model. Calcium self-efficacy is a predictor of
higher stages of dietary calcium adoption–—support-
ing the literature that higher levels of self-efficacy
(confidence) are important for dietary change. Pro-
gressively higher levels of self-efficacy in the more
advanced stages of change have been found in pre-
vious osteoporosis research,33 by exercise research-
ers43,61 and in diet studies.36
Based on the literature review of knowledge and
health behavior, related to osteoporosis, muchneeds to be done to bridge the gap between patients
and practitioners. Especially since most patients
lack the skill or knowledge to evaluate their diet
based on nutrient intake and therefore have little or
no awareness of how their current behavior com-
pares with a specified goal.62 Persons with epilepsy,
like other chronic health conditions, need effective
communication from their healthcare practitioner.
Stage-based education, for persons with epilepsy,
tailored to improve self-efficacy may therefore help
persons move people through the osteoprotective
decision making process more effectively.
In patient care it is always of primary clinical
importance to optimize seizure treatment by balan-
cing the goal of seizure freedom with the potential
adverse effects of medication, surgery and/or other
treatments. Hence, until clinical care is stabilized, it
is realistic to recognize that prevention is often a
lower priority. Since epilepsy self-efficacy was not a
predictor in any of the models or correlated with any
of the stages of the PAPM it follows that effective
communication about osteoprotective behaviors
may be very different than that of epilepsy specific
self-management. In light of the poor insight into
their condition,63 patient education efforts still need
to enhance epilepsy self-management.
Previous research has found that exercise can
improve seizure control in patients.64 The lack of
understanding among many health professionals
about epilepsy must also be addressed since unne-
cessary restriction of physical activity can have a
profound effect on bone health as well as mortality,
morbidity and quality of life. Exercise participation
recommendations should be reviewed with regards
to seizure control, medications, proper diet, rest
and the close monitoring of AED levels. If these
aspects are taken into account, then persons with
epilepsy can participate in most types of physical
activity, including some contact sports.65 Further
examination of relapse and the reasons for it are
needed since few people give up entirely, some
think about exercising again and many reduce the
amount they exercise.61
Interventions also need to focus on the need for
relapse prevention among those who are presently
consuming enough calcium.66 Lactose intolerance,
the perception that milk is for children, substituting
soft drinks for milk, eating away from home, having
few role models who drink milk and problems
related to transportation and storage are barriers
that have been documented to decrease milk con-
sumption in non-Caucasian populations.67 One area
that may help improve education is the use of
culturally relevant materials.
Medical training teaches health professionals to
organize knowledge according to disease history,
Precaution adoption process model in epilepsy 435etiology, symptoms, treatment options and side
effects. Therefore, most clinic-based educational
materials are written in this ‘‘medical model’’ for-
mat. Patient materials that focus on facts only
and use medical terms foreign to the general
public are less effective.68 These materials are
not stage-based and often have little in the way
of behavioral aspects, needed to improve self-effi-
cacy. In addition, epilepsy clinic education materi-
als (mostly provided by the pharmaceutical
companies) are often written at a level that
exceeds the readability of most patients.69 Pic-
tures, drawings or actors used in patient education
materials need to represent various ages, genders,
ethnic groups and body types so that patients can
identify with them.
Stage models of health behavior are likely to be
most accurate among people who have been
exposed to the health issue recently in their daily
lives.37 While the availability of stages-based osteo-
porosis education materials is limited and results of
trials have been mixed41,70 there are strategies
which health professionals can utilize. The use of
open-ended questions are more effective at helping
patient’s identify barriers and potential solutions
leading to increased self-efficacy. Clinic-based
health educators and nurses knowledgeable of
osteoprotective concepts may also help facilitate
the adoption of osteoprotective behaviors.
The use of a brief assessment tool such as the one
developed by Blalock et al.71 may help practitioners
assess patients’ calcium intake within the short
timeframe of an appointment. For people to
become engaged in the behavior change process,
they must not only become aware of a particular
health problem and the recommended precautions,
they must also know whether or not their current
behavior meets the recommended guidelines.66 Pro-
viding feedback to women about calcium intake
decreased those in the unengaged stage by 23% in
one prospective study of stage matched educational
materials, while the action-based plan (stage 5 of
the PAPM) was not associated with changes in knowl-
edge or beliefs.41Study limitations
Since patients at a tertiary academic medical center
are often more refractory to treatment, the differ-
ences we found may be higher when compared with
a well-controlled epilepsy population seen only by
primary care. The overall response rate was low
(42%) in our population. Since no stipend was
offered this may have resulted in a lower than
expected response rate. This may be also be dueto the length of the survey. There were a total of 146
questions in the survey packet. Only five patients
verbally declined to participate, but many more
failed to return the survey despite being given a
self-addressed stamped envelope. This may be due
to issues of low literacy in our population. Several
subjects were assisted after their clinic visit to
overcome difficulties with readability. Opportu-
nities to address this issue with those patients
receiving a mailed survey are much lower. By com-
bining stages in the statistical analysis we misclas-
sified people based on the PAPM concept. However,
despite the blurring of distinction between stages
our analyses are consistent with the theoretical
concepts within the stages of change concept.
The use of a cross sectional study design also has
its limitations.Conclusions
Overall, this study adds to the understanding of
knowledge, health behavior and self-efficacy related
to the prevention adoption process in persons with
epilepsy, a population at significant risk for bone loss
and fractures. Previous studies of non-epilepsy popu-
lations have found that knowledge related to calcium
orexercisewerenot predictors of behavior. However,
in this studyof personswith epilepsy itwas found that
knowledge of osteoprotective exercise is critical in
later stages of adoption for exercise and dietary
calcium. Age and perceived susceptibility were
strong predictors of higher stages of calcium supple-
ment use and DEXA screening.
One major challenge in epilepsy care is to
enhance osteoprotective behaviors such as
increased dietary calcium, calcium (with vitamin
D) supplementation, exercise and DEXA screening
in younger patients, a population who tend to not
perceive themselves at risk for bone loss. In this
study, persons who were unaware or unengaged
perceived the lowest susceptibility for osteoporosis
and those in maintenance the highest. In epilepsy
care these extremes may be a majority of patients
since previous studies indicated only 41% of pedia-
tric and 28% of adult neurologists routinely evaluate
AED-treated patients for bone mineral disease.72 In
addition, previous studies of person with epilepsy
found 75% were unaware of bone loss as a side
effect of their medication.5 The results of this study
indicate that neurologists and epilepsy specialists
need to discuss osteoprotective behaviors with their
patients. To capitalize on the opportunities
addressed in this research the next step is to design
and evaluate osteoprotective educational interven-
tions for persons with epilepsy. By understanding
436 J.O. Elliott et al.issues important to patients and optimizing educa-
tional opportunities based on a stage-based model,
such as the PAPM, we may find ways to be more
successful at promoting the adoption of osteopro-
tective behaviors.References
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